25 junio 2021

Llega al Mercado un Fármaco Para el Tratamiento de COVID19 de Roche / Genentech . Tocilizumab ( Actemra ) . FDA Authorizes Drug For Treatment of COVID19 .

 SILVER SPRING, Md.June 24, 2021 /PRNewswire/ -- 

Today, The U.S. Food and Drug Administration Issued an Emergency Use Authorization (EUA) For The Drug Actemra ( Tocilizumab ) For The Treatment of Hospitalised Adults and Pediatric Patients ( 2 Years of Age and Older ) Who Are Receiving Systemic Corticosteroids and Require Supplemental Oxygen, Non-Invasive or Invasive Mechanical Ventilation, or Extracorporeal Membrane Oxygenation (ECMO) .

...